Medtronic

Medtronic Competitive Intelligence & Landscape

medtronic.com ·

Overview

Medtronic Overview

Medtronic (medtronic.com) is a global leader in healthcare technology, committed to "alleviate pain, restore health, and extend life" for millions worldwide [https://investorrelations.medtronic.com/overview]. The company addresses challenging health problems by developing innovative solutions, from the world's smallest pacemaker to robotic-assisted surgery and advanced neurovascular care [https://www.medtronic.com/en-us/our-company.html]. Their focus includes leveraging technologies like AI and connected care to build a bridge to better health for more people, emphasizing personalized healthcare solutions [https://global.medtronic.com/xg-en/our-company.html].

Founded over 75 years ago, Medtronic has a rich history of pioneering groundbreaking health technology, starting from humble beginnings in a garage workshop [https://www.medtronic.com/en-us/our-company/history.html]. The company is headquartered at 710 Medtronic Parkway, Minneapolis, MN 55432-5604 USA [https://www.medtronic.com/en-us/contact-us.html]. With a substantial global presence, Medtronic employs over 95,000 individuals, including more than 13,600 scientists and engineers dedicated to innovation [https://www.medtronic.com/content/dam/medtronic-wide/public/brand-corporate-assets/company-story/doc-corpmark-factsheet-scrolling-en.pdf].

Medtronic's core products and services span a wide array of healthcare technologies that improve the lives of a vast target market. In a recent year, their therapies positively impacted over 79 million people, demonstrating their significant reach and impact on human health [https://www.medtronic.com/content/dam/medtronic-wide/public/brand-corporate-assets/company-story/doc-corpmark-factsheet-scrolling-en.pdf]. The company is focused on delivering patient-centered solutions across numerous health conditions, striving to transform lives globally through their technological advancements [https://www.medtronic.com/en-us/our-company.html].

Medtronic

Medtronic Weekly Intel Updates

Receive weekly intel updates about Medtronic straight to your inbox.

Competitors

Medtronic Competitors

Medtronic (medtronic.com) faces competition from several key players in the medical device and healthcare technology sectors. One prominent competitor is Boston Scientific, which, along with Sanofi, Olympus Corporation, and Brainlab, is recognized as a competitor to Medtronic according to Comparably. While Medtronic ranks first in Customer Net Promoter Score among these, Boston Scientific is also a significant presence, especially in competitive deals as identified by sales reps [https://www.comparably.com/companies/medtronic/competitors]. In the Cardiac Rhythm Management market specifically, Boston Scientific is a top competitor, despite a past recall of their Implantable Cardioverter Defibrillator [https://idataresearch.com/top-medtronic-competitors-in-the-united-states/].

Another major competitor is Abbott, which includes St. Jude Medical.

Abbott has made gains in the Cardiac Rhythm Management market, and despite a recall of their Sprint Fidelis® defibrillation lead in 2007, they continue to lead the market by a wide margin in certain areas [https://idataresearch.com/top-medtronic-competitors-in-the-united-states/].

Abbott is also listed among Medtronic's top competitors by Owler, alongside Boston Scientific and C. R. Bard [https://www.owler.com/company/medtronic/competitors].

Stryker is frequently encountered as a competitor by Medtronic sales professionals in competitive deals [https://www.repvue.com/companies/Medtronic/competitors].

Stryker is a global medical technology company known for its diverse product portfolio, including surgical technologies, neurotechnology, and orthopaedics, placing it in direct competition with Medtronic's offerings in robotic-assisted surgery and various medical devices [https://medtronic.com/].

Johnson & Johnson is another broad-reaching competitor to Medtronic, offering a wide array of medical devices, pharmaceuticals, and consumer health products [https://www.owler.com/company/medtronic/competitors]. Like Medtronic, Johnson & Johnson is a diversified healthcare company with significant market share across multiple segments, including surgical technologies and implantable devices, which are key monetization areas for Medtronic [https://businessmodelcanvastemplate.com/blogs/competitors/medtronic-competitive-landscape].

Product & Pricing

Medtronic Product and Pricing Intelligence

Medtronic (medtronic.com) offers a diverse portfolio of medical technologies, devices, and therapies, with product and pricing intelligence tailored for healthcare professionals and organizations. While specific pricing details are often accessible through direct inquiries or customer portals, Medtronic provides resources for understanding product costs and reimbursement. For instance, customers can request product pricing information directly through the website, and there are dedicated sections for healthcare professionals to explore products and order options [https://www.medtronic.com/en-us/healthcare-professionals/products.html].

Medtronic operates a digital platform called Medtronic Connect eStore, which facilitates real-time product ordering, tracking, and invoicing. This eStore offers options for ordering products and receiving information that can be customized to suit a hospital or clinic's unique environment. Users can sign up for viewer access to monitor order history, track packages, and download invoices and delivery notes [https://www.medtronic.com/au-en/c/medtronic-connect.html]. Payment terms for some products, such as implantable neurostimulation systems, specify "Net 30 days from date of invoice," and prices are subject to change without notice [https://www.medtronic.com/content/dam/medtronic-wide/public/united-states/products/neurological/scs-us-product-list.pdf].

For certain products, Medtronic offers various payment structures and support. For example, in Canada, continuous glucose monitoring (CGM) products may be available in monthly installments as low as CAD $99 for 12 months, which includes a $300 discount on the retail price [https://www.medtronic.com/en-ca/diabetes/experiences/cgm-access.html]. Additionally, Medtronic provides service plans to protect investments in their products, aiming to make equipment maintenance convenient and cost-effective for healthcare organizations [https://www.medtronic.com/content/dam/medtronic-wide/public/united-states/products/digestive-gastrointestinal/gastroenterology-products-service-plan-brochure.pdf].

Hiring & Layoffs

Medtronic Hiring and Layoffs

Medtronic (medtronic.com) actively promotes a philosophy of creating rewarding careers and improving lives through its workforce [medtronic.com/en-us/our-company/careers.html]. The company emphasizes building futures with them, encouraging individuals to gain new skills and develop careers that reflect their intelligence, passion, and unique abilities [global.medtronic.com/xg-en/our-company/careers.html]. While specific recent hiring trends are not detailed on the available homepage content, the consistent messaging across multiple country-specific career pages suggests an ongoing commitment to recruitment.

Medtronic places a significant emphasis on engineering opportunities, with dedicated sections for engineering careers across various disciplines. These include hardware, software, quality, manufacturing, systems, and research & development [medtronic.com/en-us/our-company/careers/engineering.html]. The company views all its employees as "engineers at heart," working to generate innovative solutions [medtronic.com/en-gb/our-company/careers/engineering.html]. This focus on engineering signals a strategic drive towards innovation and development within the medical technology sector.

Furthermore, Medtronic has a strong focus on early careers, offering diverse technical and business opportunities for recent graduates [medtronic.com/en-us/our-company/careers/early-careers.html]. They provide platforms for new talent to develop their skills and have been recognized as a top employer for new graduates, earning accolades like Forbes Magazine's Best Employers for New Graduates in 2025 and the Handshake Early Talent Award in 2025 [medtronic.com/en-ie/our-company/careers/early-careers.html]. This commitment to nurturing early talent indicates a long-term strategy for talent acquisition and development.

There is no information about layoffs in the provided search results; instead, the company consistently highlights its active recruitment and career development programs globally. The emphasis on growth, skill development, and diverse opportunities for both experienced professionals and recent graduates suggests a stable to growing workforce strategy aimed at sustained innovation and market presence.

Medtronic also ensures equal employment opportunities, further demonstrating its commitment to a diverse and inclusive talent pool [global.medtronic.com/xg-en/our-company/careers.html].

Leadership

Medtronic Management and Leadership Team

The leadership at Medtronic (medtronic.com) is spearheaded by Geoff Martha, who serves as both Chairman and CEO. He assumed the CEO role in 2020 and became Chairman later that same year [medtronic.com/en-us/our-company/governance/board-committees/board-directors.html]. The executive team is dedicated to advancing healthcare technology and solving global health challenges [medtronic.com/en-ca/our-company/leadership.html].

Key members of the leadership team include Thierry Piéton as Executive Vice President and Chief Financial Officer, overseeing the global Finance organization [medtronic.com/en-us/our-company/leadership/thierry-pieton.html].

Laura Mauri, M.D., M.Sc., holds the position of Senior Vice President, Chief Scientific and Medical Officer, responsible for the company's scientific, medical, clinical research, and regulatory affairs functions [medtronic.com/en-us/our-company/leadership/laura-mauri.html].

Further crucial executives include Rogerio Branco, SVP & Chief Operations and Supply Chain Officer, and Scott Cundy, SVP & Chief Quality Officer [medtronic.com/en-us/our-company/leadership.html].

Que Dallara is EVP & President of Diabetes, while Harry “Skip” Kiil is the Executive Vice President and President of Medtronic’s Cardiovascular Portfolio, leading a global team in delivering transformative cardiovascular therapies [medtronic.com/en-ca/our-company/leadership.html, medtronic.com/en-us/our-company/leadership/skip-kiil.html]. These individuals form the core of Medtronic's management, driving its mission in healthcare innovation.

Financials

Medtronic Financial Performance, Fundraising, M&A

Medtronic (medtronic.com), a global leader in healthcare technology, has demonstrated robust financial performance, evidenced by consistent revenue growth. For fiscal year 2026 (FY26), which ended April 24, 2026, the company reported a total revenue of $36.4 billion, reflecting an 8.4% increase as reported and 5.8% organic growth. This marked Medtronic's highest annual revenue growth in 10 years [https://news.medtronic.com/2026-06-03-Medtronic-reports-fourth-quarter-and-full-year-fiscal-2026-results-delivers-highest-annual-revenue-growth-in-10-years]. In the preceding fiscal year, FY25, Medtronic achieved $33.5 billion in revenue, representing a 3.6% increase [https://news.medtronic.com/2025-05-21-Medtronic-reports-strong-finish-to-its-fiscal-year-with-its-fourth-quarter-financial-results-announces-dividend-increase]. The company also invests significantly in research and development, with $2.7 billion dedicated to R&D in FY25 [https://medtronic.com/].

Quarterly results further illustrate Medtronic's strong financial trajectory. In the fourth quarter of FY26 (Q4 FY26), the company's revenue reached $9.8 billion, a 9.9% increase as reported and 6.6% organic growth [https://news.medtronic.com/2026-06-03-Medtronic-reports-fourth-quarter-and-full-year-fiscal-2026-results-delivers-highest-annual-revenue-growth-in-10-years]. This followed solid performances in earlier quarters of FY26, with Q3 FY26 revenue at $9.0 billion (8.7% reported, 6.0% organic) [https://news.medtronic.com/2026-02-17-Medtronic-reports-strong-third-quarter-fiscal-2026-results-with-highest-enterprise-revenue-growth-in-10-quarters], Q2 FY26 revenue at $9.0 billion (6.6% reported, 5.5% organic) [https://news.medtronic.com/2025-11-18-Medtronic-reports-strong-second-quarter-fiscal-2026-financial-results,-enterprise-growth-drivers-accelerate-momentum], and Q1 FY26 revenue at $8.6 billion (8.4% reported, 4.8% organic) [https://news.medtronic.com/2025-08-19-Medtronic-reports-first-quarter-fiscal-2026-financial-results].

Medtronic is publicly traded on the NYSE under the ticker MDT, and actively engages with shareholders, providing regular updates through its investor relations website [https://investorrelations.medtronic.com/] which includes quarterly earnings reports, news releases, and financial information [https://investorrelations.medtronic.com/fundamentals?r=I]. The company also holds annual meetings for its shareholders [https://investorrelations.medtronic.com/annual-meeting-reports]. These activities underscore Medtronic's commitment to transparency and creating value for its investors through diversified growth and earnings power [https://medtronic.com/]. While specific details on fundraising rounds and M&A activities were not explicitly detailed in the provided content, the consistent organic growth and significant R&D investments indicate a strong financial foundation supporting ongoing innovation and potential strategic expansions.

Partnerships

Medtronic Partnerships, Clients and Vendors

Medtronic (medtronic.com) actively cultivates strategic partnerships and technology integrations to enhance patient care and expand access to its healthcare solutions. The company collaborates with leading medical device manufacturers to deliver vital parameter technologies, empowering clinicians with real-time information for individualized treatment decisions [https://acmstratallianceintegrations.medtronic.com/]. These extensive partnerships underscore Medtronic's commitment to innovation and its role in the broader medical technology ecosystem.

Key partnerships include a significant collaboration with Philips, aimed at expanding access to patient monitoring technology [https://news.medtronic.com/Medtronic-announces-strategic-partnership-with-Philips-to-expand-access-to-patient-monitoring-technology].

Medtronic has also broadened its multi-year global strategic alliance with GE HealthCare, focusing on accelerating next-generation technology innovation, increasing access to integrated clinical solutions, and strengthening collaboration across patient care [https://news.medtronic.com/Medtronic-expands-multiyear-global-strategic-alliance-with-GE-HealthCare-designed-to-accelerate-next-generation-technology-innovation,-increase-access-to-integrated-clinical-solutions,-and-strengthen-collaboration]. This collaboration with GE HealthCare has led to the integration of Medtronic's advanced INVOS™ regional oximetry and Microstream™ capnography technologies on the CARESCAPE platform, enhancing personalized patient monitoring [https://news.medtronic.com/2022-06-01-GE-Healthcare,-Medtronic-partnership-accelerates-global-access-to-personalized-care-by-delivering-advanced-patient-monitoring-solutions-on-the-CARESCAPE-platform].

Further demonstrating its ecosystem relationships, Medtronic has a global partnership with Abbott concerning continuous glucose monitoring (CGM) technology, with Medtronic advancing this partnership through FDA submissions for interoperable insulin pumps [https://news.medtronic.com/2025-04-24-Medtronic-advances-Abbott-CGM-partnership-with-FDA-submission-of-interoperable-insulin-pump], and announcing FDA approval for its Simplera™ CGM [https://news.medtronic.com/2024-08-07-Medtronic-announces-FDA-approval-of-Simplera-TM-CGM-and-global-partnership-with-Abbott]. Other notable collaborations include a strategic agreement with KARL STORZ to expand access to integrated ENT surgical solutions in the U.S. [https://news.medtronic.com/2026-06-04-Medtronic-and-KARL-STORZ-Announce-Strategic-Collaboration-to-Expand-Access-to-Integrated-ENT-Surgical-Solutions-in-the-U-S], a distribution agreement with Merit Medical Systems, Inc. to offer the FDA-cleared ViaVerte™ system for chronic lower back pain [https://news.medtronic.com/2026-03-24-Medtronic-and-Merit-Medical-Systems-enter-into-agreement-to-offer-new,-FDA-cleared-ViaVerte-TM-system,-a-basivertebral-nerve-ablation-treatment-for-chronic-vertebrogenic-lower-back-pain], and an expanded strategic partnership with Mindray North America to extend beyond hospitals to ambulatory surgery centers, integrating next-generation Medtronic monitoring technologies [https://news.medtronic.com/Medtronic-and-Mindray-North-America-broaden-strategic-partnership-beyond-hospitals-to-ambulatory-surgery-centers-across-the-U-S].

Additionally, Medtronic has partnered with Novo Nordisk to provide integrated digital solutions for people with diabetes, aiming to share dosing data from Novo Nordisk smart insulin pens with Medtronic continuous glucose monitoring devices [https://news.medtronic.com/2019-09-16-Medtronic-and-Novo-Nordisk-Enter-Agreement-to-Provide-Integrated-Digital-Solutions-for-People-with-Diabetes]. These strategic alliances highlight Medtronic's commitment to advancing healthcare through collaborative efforts with diverse partners across the medical technology landscape, ultimately benefiting patients and clinicians globally.

Events

Medtronic Event Participations

Medtronic actively participates in and hosts numerous events to educate healthcare professionals and advance medical innovation. Through the Medtronic Academy, the company provides access to over 4,000 courses and videos, and allows participants to attend live or recorded webinars and events [https://www.medtronic.com/en-us/healthcare-professionals/education-training/medtronic-academy.html]. This platform serves as a central hub for continuous learning, featuring interactive courses, case studies, and insights from industry leaders through scientific exchange webinars [https://global.medtronic.com/xg-en/healthcare-professionals/education-training.html].

Medtronic is a significant presence at major medical conferences, such as the ESC Congress 2025, where they will drive cardiovascular innovation through satellite symposia and tutorial sessions, discussing topics like the latest innovations in device therapy for cardiac rhythm management and reimagining hypertension care [https://www.medtronic.com/en-ie/l/d/emea/cardiac-rhythm/esc.html]. Similarly, at the EACTS 2025 Congress, Medtronic will host symposia and a dedicated training center to explore new horizons in cardiac surgery, offering multidisciplinary medical education sessions, product demonstrations, wetlabs, drylabs, and simulators [https://www.medtronic.com/en-ie/l/d/emea/cardiovascular/eacts.html].

The company also frequently hosts webinars for healthcare professionals, covering a range of specialties. For instance, their diabetes division offers on-demand webinars on topics like navigating patient cost and coverage of MiniMed therapies [https://www.medtronic.com/en-us/healthcare-professionals/specialties/diabetes/education-resources/webinars.html]. Furthermore, Medtronic provides surgical education webinars for colorectal, gynecologic, hernia, metabolic & obesity, and thoracic specialties [https://www.medtronic.com/patient-monitoring-respiratory/en-us/clinical-education/catalog/surgical-education-webinar-library.html]. These digital events, along with Global Grand Rounds interactive webcasts, allow healthcare professionals to engage with industry-leading experts and learn about emerging technologies and solutions in various medical fields [https://www.medtronic.com/in-en/healthcare-professionals/medical-specialties/cardiology/cardiovascular-surgery.html].

Frequently Asked Questions

What is Medtronic's strategy for maintaining its competitive edge and driving innovation in healthcare technology?

Medtronic's strategy for maintaining its competitive edge involves a significant emphasis on engineering, with dedicated career paths in hardware, software, quality, manufacturing, systems, and R&D. The company also fosters innovation through continuous education via the Medtronic Academy, participation in major medical conferences like ESC and EACTS Congresses, and strategic partnerships with other industry leaders to develop integrated clinical solutions.

How do Medtronic's recent financial results indicate its market position and growth trajectory?

Medtronic's financial results demonstrate robust growth, with FY26 revenue reaching $36.4 billion, an 8.4% increase and 5.8% organic growth, marking its highest annual revenue growth in 10 years. This consistent growth, alongside a $2.7 billion investment in R&D in FY25, indicates a strong market position and a positive trajectory driven by innovation and diversified offerings.

What is Medtronic's approach to talent acquisition and development, particularly concerning early career professionals?

Medtronic emphasizes a long-term talent acquisition and development strategy, focusing on building rewarding careers and skill development. The company offers diverse technical and business opportunities for recent graduates, providing platforms for new talent to grow. It has been recognized as a top employer for new graduates by Forbes Magazine and Handshake in 2025, indicating a strong commitment to nurturing early career professionals.

What does Medtronic's extensive event participation and educational initiatives signal about its strategic priorities?

Medtronic's extensive event participation and educational initiatives signal a strategic priority on continuous learning, scientific exchange, and driving medical innovation. Through the Medtronic Academy and presence at conferences like ESC and EACTS, the company educates healthcare professionals on new device therapies and surgical techniques, aiming to advance medical practices and showcase its leadership in healthcare technology.

How does Medtronic's leadership structure support its goal of advancing healthcare technology?

Medtronic's leadership structure, headed by Chairman and CEO Geoff Martha, includes specialized executives like Thierry Piéton as CFO, Laura Mauri as Chief Scientific and Medical Officer, and Rogerio Branco overseeing operations and supply chain. This specialized team, including leaders for the Cardiovascular Portfolio and Diabetes, is designed to drive the company's mission by focusing on financial performance, scientific advancement, operational excellence, and portfolio-specific innovation.

What competitive landscape does Medtronic navigate, and how do key competitors like Boston Scientific and Abbott challenge its market share?

Medtronic navigates a competitive landscape including Boston Scientific, Abbott (with St. Jude Medical), Stryker, and Johnson & Johnson. Boston Scientific is a significant presence in cardiac rhythm management, while Abbott has made gains in the same market and leads in other areas despite past recalls. These competitors challenge Medtronic by offering diverse medical devices, often with strong presences in specific segments like interventional cardiology or diagnostic solutions.

Which companies offer strong alternatives to Medtronic, and what are their differentiating factors?

Strong alternatives to Medtronic include Abbott, Boston Scientific, Johnson & Johnson MedTech, GE Healthcare, and B. Braun. Abbott and Boston Scientific compete broadly in medical devices, with Boston Scientific emphasizing interventional cardiology. Johnson & Johnson MedTech offers a wide portfolio including surgical and orthopedic solutions. GE Healthcare specializes in imaging and diagnostic platforms, while B. Braun focuses on infusion therapy and cost-effective solutions for a broad audience.

What is Medtronic's strategy for expanding access to its patient monitoring technologies?

Medtronic's strategy for expanding access to patient monitoring technologies involves strategic partnerships with other medical device manufacturers. Notable collaborations include a partnership with Philips to expand access to patient monitoring technology, and an expanded alliance with GE HealthCare to integrate advanced monitoring solutions like INVOS™ regional oximetry and Microstream™ capnography onto the CARESCAPE platform.

How is Medtronic leveraging partnerships to advance its diabetes care solutions?

Medtronic is leveraging partnerships to advance its diabetes care solutions through global collaborations. This includes an ongoing partnership with Abbott concerning continuous glucose monitoring (CGM) technology, with Medtronic advancing FDA submissions for interoperable insulin pumps. Additionally, Medtronic has partnered with Novo Nordisk to integrate digital solutions for people with diabetes, aiming to share dosing data between smart insulin pens and Medtronic CGM devices.

How does Medtronic streamline product ordering and provide pricing transparency for healthcare organizations?

Medtronic streamlines product ordering and aims for pricing transparency through its Medtronic Connect eStore, an online platform for real-time ordering, tracking, and invoicing. This platform allows customized options for hospitals and clinics, enabling users to monitor order history and download invoices. While specific pricing requires direct inquiry, payment terms are generally Net 30 days, and service plans are offered for equipment maintenance.

What is the strategic significance of Medtronic's expanded partnership with GE HealthCare?

Medtronic's expanded multi-year global strategic alliance with GE HealthCare is strategically significant as it aims to accelerate next-generation technology innovation, increase access to integrated clinical solutions, and strengthen collaboration across patient care. This partnership has already led to the integration of Medtronic's advanced INVOS™ regional oximetry and Microstream™ capnography technologies onto GE HealthCare's CARESCAPE platform, enhancing personalized patient monitoring.

Powered by ForesightIQ · Competitive intelligence from digital exhaust